Medical Devices for Cardiovascular Diagnostics and Interventional Procedures
HEART DISEASE, PCI & THE MARKET
The U.S. Center for Disease Control and Prevention estimates that the treatment of heart disease in the U.S. alone costs the nation $200 billion per year and 121 million people have cardiac issues. Cardiovascular Disease (CVD), a form of heart disease, is the number one cause of death globally. Interventional cardiology most often treats CVD by performing a percutaneous coronary intervention (PCI) procedure, in which balloon angioplasty will clear the blockage in an artery, and implanting a stent will keep the artery open for proper blood flow.
Based on a review of medical journal articles, public databases, industry knowledge, and independent market research, Accumed Radial believes the following to be a reasonable approximation of the total annual U.S. market size: 2.1 million cardiac catheterization procedures total, of which 965,000 are PCI procedures. Transradial access (TRA) is one way of conducting a catheterization procedure. It is used approximately 45% of the time and is expected to grow to 70% or higher in the next few years.
“According to the latest interventional cardiology procedural analysis by iData Research, over 965,000 angioplasties are done each year in the United States. An angioplasty, also known as percutaneous coronary intervention (PCI) . . .”
iData Research – September 2018